• Research Faculty

  • A photo of Prasad Devarajan.

    Prasad Devarajan, MD Director, Division of Nephrology and Hypertension

    researches acute kidney injury mechanisms, biomarkers and novel therapies. He also studies focal segmental glomerulosclerosis pathogenesis and biomarkers; and lupus nephritis molecular pathways and biomarkers. For each condition, his team employs an integrated approach of genomic and proteomic discovery in animal and human models, followed by translation, and validation in the human disease states.
    Visit the Devarajan Lab.

    513-636-4531

    A photo of Michael Bennett.

    Michael R. Bennett, PhD Director, Biomarker Laboratory

    research interests include developing early diagnostic markers for pediatric diseases, such as acute kidney injury, nephrotic syndrome and lupus nephritis. Dr. Bennett is also interested in unraveling the etiology of focal segmental glomerulosclerosis by studying both the underlying genetic and proteomic patterns associated with the disease. 

    513-636-8349

    A photo of Bradley P. Dixon.

    Bradley P. Dixon, MD Pediatric Nephrologist

    focuses on the recognition and repair of DNA damage within the urinary microenvironment, specifically as it relates to the increased risk of malignancy in the augmented bladder. Dr. Dixon also has clinical and translational research interests in complement-mediated diseases such as atypical hemolytic uremic syndrome, as well as cystic kidney diseases such as tuberous sclerosis and polycystic kidney disease.
    Visit the Dixon Lab.

    513-636-4531

    A photo of Elif Erkan.

    Elif Erkan, MD, MS Pediatric Nephrologist, Division of Nephrology

    is a physician scientist whose research interests are proteinuria induced injury in the kidney and the mechanism of albumin endocytosis in the proximal tubule epithelial cells. Her laboratory studies the protein-protein interactions between endocytic receptors/adapters and protein kinases that are involved in cell signaling events.

    513-636-4531

    A photo of Jens W. Goebel.

    Jens W. Goebel, MD Clinical Director, Nephrology and Hypertension

    is involved in multi-center projects investigating non-invasive predictors of kidney transplant outcome and the influence of immunosuppressive regimens on transplantation tolerance. He is also conducting collaborative studies of the pharmacokinetics, genetics and dynamics of drugs used for anti-rejection prophylaxis, and participating in efforts to better understand our patients’ adherence to their immunosuppressive regimen.

    513-636-4531

    A photo of Stuart L. Goldstein.

    Stuart L. Goldstein, MD Director, Center for Acute Care Nephrology

    focuses on all aspects of acute kidney injury (AKI) spanning from translational work in AKI biomarker validation to long-term AKI epidemiology and outcomes. He is specifically interested in improving outcomes in the critically ill child with or at risk for AKI.

    513-803-3295

    A photo of Dr. David Hooper.

    David K. Hooper, MD, MS Pediatric Nephrologist, Division of Nephrology

    aims to improve clinical outcomes for pediatric kidney transplant recipients through research in personalized care and the design of systems capable of delivering that care with high reliability. His primary focus is the prevention of cardiovascular disease through a combination of quality improvement and clinical/translational research methods.

    513-636-4531

    A photo of Elizabeth Jackson.

    Elizabeth C. Jackson, MD Director, Healthy Bladder Clinic

    has clinical research in types of bedwetting alarms that are useful for nocturnal enuresis, in outcomes of neurogenic bladder, and in the relationship of obesity and kidney stones as well as industry sponsored research in anticholinergics for neurogenic bladder.

    513-636-4975

    No photo available

    Paul T. McEnery, MD, MBA

    has focused his career on the research of membranoproliferative glomerulonephritis and is a key member of the North American Pediatric Renal Transplant Consortium data base. Besides his research in transplantation and immune-mediated renal disease, he also was responsible for bringing the Ronald McDonald House to Cincinnati Children's as well as initiating dialytic therapy for children in Cincinnati.

    513-636-8652

    A photo of Mark Mitsnefes.

    Mark M. Mitsnefes, MD, MS Director, Clinical and Translational Research Center

    is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.

    513-636-0125

    A photo of Edward Nehus.

    Edward J. Nehus, MD, MS Pediatric Nephrologist

    is a pediatric nephrologist who has conducted clinical research in chronic kidney disease and critical care nephrology.  His primary area of research is studying pharmacokinetic alterations in critically ill children receiving continuous renal replacement therapy.  Other research interests include studying cardiovascular risk factors and glomerular filtration rate estimation in children with chronic kidney disease.

    513-636-4531

    A photo of Brian Siroky.

    Brian J. Siroky, PhD Research Associate, Division of Nephrology and Hypertension

    focuses on understanding the mechanisms of renal cyst and tumor formation that occur in tuberous sclerosis complex (TSC), and identification of targeted therapies for these lesions. Structural and functional relationships between renal epithelial primary cilia (specialized cellular organelles whose dysfunction is linked to cystogenesis) and mTOR signaling, the pathway that is dysregulated in TSC is also an area of interest.

    513-636-4497

    A photo of Frederic Strife.

    C. Frederic Strife, MD Emeritus Professor

    has focused his research career around immune-mediated renal disease and membranoproliferative glomerulonephritis in particular. Furthermore, Dr. Strife also has been active in understanding how to improve the care of the pediatric dialysis patient.

    513-636-4531

    A photo of Rene Van de Voorde.

    Rene G. Van De Voorde III, MD Medical Director, Dialysis Unit

    focuses on clinical research in the sequelae, treatment, and outcomes of chronic kidney disease, including end stage renal disease. He is currently involved in drug trials and research projects on the treatment of anemia (2 studies), bone and mineral disease (3 studies), poor growth, cardiovascular disease, and quality of life (1 study each).

    513-636-4531